{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:30:19Z","timestamp":1790728219637,"version":"4.1.0"},"reference-count":66,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Reports"],"abstract":"<jats:p>Type 1 diabetes mellitus (T1DM) is regarded as the most chronic autoimmune disease affecting children and adolescents that results from a destruction of pancreatic \u03b2-cell and leads to insulin insufficiency and persistent hyperglycemia (HG). Children and adolescents with T1DM are at an increased risk of developing microvascular complications, including diabetic nephropathy (DNE), diabetic retinopathy (DR), and diabetic neuropathy (DNU). The risk factors and prevalence of these complications differ greatly in pediatric studies. Screening for T1DM microvascular complications undergoes different stages and it is recommended to identify early symptoms and clinical signs. The identification of biomarkers in T1DM microvascular complications is needed to provide optimal treatment. Despite several studies on early biomarkers for DNE in children, the potential biomarkers for predicting DR and DNU have not been completely illustrated. This review fills this gap by identifying biomarkers of T1DM microvascular complications in children and adolescents through searches in the PubMed\/Medline database.<\/jats:p>","DOI":"10.3390\/pediatric16030064","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T11:15:59Z","timestamp":1725534959000},"page":"763-778","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic Biomarkers of Microvascular Complications in Children and Adolescents with Type 1 Diabetes Mellitus\u2014An Updated Review"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0619-4136","authenticated-orcid":false,"given":"Naser A.","family":"Alsharairi","sequence":"first","affiliation":[{"name":"Heart, Mind and Body Research Group, Griffith University, Gold Coast, QLD 4222, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"ref_2","unstructured":"Lucier, J., and Weinstock, R.S. (2023). Type 1 Diabetes, StatPearls."},{"key":"ref_3","unstructured":"Los, E., and Wilt, A.S. (2023). Type 1 Diabetes in Children, StatPearls."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e13562","DOI":"10.1111\/1753-0407.13562","article-title":"Epidemiology of type 1 diabetes mellitus in children and adolescents: A 50-year, single-center experience","volume":"16","author":"Kandemir","year":"2024","journal-title":"J. Diabetes"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107842","DOI":"10.1016\/j.diabres.2019.107842","article-title":"Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Patterson","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"109083","DOI":"10.1016\/j.diabres.2021.109083","article-title":"Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas, 10th edition","volume":"183","author":"Ogle","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00125-019-4942-x","article-title":"Early-life factors contributing to type 1 diabetes","volume":"62","author":"Craig","year":"2019","journal-title":"Diabetologia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1573396320666230822095948","article-title":"Dietary factors associated with glycemic control in children and adolescents with type 1 diabetes","volume":"21","author":"Zakarneh","year":"2023","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MOP.0000000000001353","article-title":"Disordered eating in adolescents with type 1 diabetes: Risk factors and screening recommendations","volume":"36","author":"Clary","year":"2024","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/dci18-0023","article-title":"Type 1 diabetes in children and adolescents: A position statement by the American Diabetes Association","volume":"41","author":"Chiang","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_11","first-page":"146","article-title":"Diabetes in childhood and adolescence","volume":"115","author":"Ziegler","year":"2018","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Huang, A., Chen, Q., Yang, W., Cui, Y., Wang, Q., and Wei, H. (2023). Clinical characteristics of 683 children and adolescents, aged 0-18 years, newly diagnosed with type 1 diabetes mellitus in Henan Province: A single-center study. BMC Pediatr., 23.","DOI":"10.1186\/s12887-023-03847-z"},{"key":"ref_13","first-page":"e35435","article-title":"Prevalence and associated clinical features of type 1 diabetes mellitus among children presented to a tertiary health care center of himalayan foothills","volume":"15","author":"Verma","year":"2023","journal-title":"Cureus"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Diabetes Canada Clinical Practice Guidelines Expert Committee, Wherrett, D.K., Ho, J., Huot, C., Legault, L., Nakhla, M., and Rosolowsky, E. (2018). Type 1 diabetes in children and adolescents. Can. J. Diabetes, 42, S234\u2013S246.","DOI":"10.1016\/j.jcjd.2017.10.036"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S2213-8587(18)30035-4","article-title":"Macrovascular disease and risk factors in youth with type 1 diabetes: Time to be more attentive to treatment?","volume":"6","author":"Bjornstad","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Graves, L.E., and Donaghue, K.C. (2020). Vascular complication in adolescents with diabetes mellitus. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00370"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kostopoulou, E., Sinopidis, X., Fouzas, S., Gkentzi, D., Dassios, T., Roupakias, S., and Dimitriou, G. (2023). Diabetic ketoacidosis in children and adolescents; Diagnostic and therapeutic pitfalls. Diagnostics, 13.","DOI":"10.20944\/preprints202306.1909.v1"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/IJNRD.S143186","article-title":"The role of novel biomarkers in predicting diabetic nephropathy: A review","volume":"10","author":"Uwaezuoke","year":"2017","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4239\/wjd.v13.i8.587","article-title":"Diabetic kidney disease in pediatric patients: A current review","volume":"13","author":"Muntean","year":"2022","journal-title":"World J. Diabetes"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s00467-021-05347-7","article-title":"Diabetic kidney disease in children and adolescents: An update","volume":"37","author":"Lopez","year":"2022","journal-title":"Pediatr. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Rico-Fontalvo, J., Aroca-Mart\u00ednez, G., Daza-Arnedo, R., Cabrales, J., Rodr\u00edguez-Yanez, T., Cardona-Blanco, M., Montejo-Hern\u00e1ndez, J., Rodelo Barrios, D., Pati\u00f1o-Pati\u00f1o, J., and Rodr\u00edguez, E.O. (2023). Novel biomarkers of diabetic kidney disease. Biomolecules, 13.","DOI":"10.3390\/biom13040633"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/pdi.1634","article-title":"Detecting diabetes complications in children","volume":"28","author":"Bertalan","year":"2011","journal-title":"Pract. Diabetes"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00467-021-05050-7","article-title":"Early microvascular complications in type 1 and type 2 diabetes: Recent developments and updates","volume":"37","author":"Tommerdahl","year":"2022","journal-title":"Pediatr. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s11255-022-03354-7","article-title":"Novel biomarkers for prognosticating diabetic kidney disease progression","volume":"55","author":"Swaminathan","year":"2023","journal-title":"Int. Urol. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/pedi.13037","article-title":"Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center","volume":"21","author":"Porter","year":"2020","journal-title":"Pediatr. Diabetes"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/pedi.13416","article-title":"Differences in retinopathy prevalence and associated risk factors across 11 countries in three continents: A cross-sectional study of 156,090 children and adolescents with type 1 diabetes","volume":"23","author":"Bratina","year":"2022","journal-title":"Pediatr. Diabetes"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1515\/jpem-2016-0231","article-title":"Prevalence and risk factors for diabetic retinopathy in a hospital-based population of Australian children and adolescents with type 1 diabetes","volume":"29","author":"Keel","year":"2016","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1515\/jpem-2017-0417","article-title":"HbA1c levels in children with type 1 diabetes and correlation to diabetic retinopathy","volume":"31","author":"Andreasson","year":"2018","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e00197","DOI":"10.1002\/edm2.197","article-title":"Risk factors associated with retinopathy in young people with type 1 diabetes in Bangladesh","volume":"4","author":"Zabeen","year":"2020","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1038\/s41433-020-01326-8","article-title":"Risk factors for having diabetic retinopathy at first screening in persons with type 1 diabetes diagnosed under 18 years of age","volume":"35","author":"Rafferty","year":"2021","journal-title":"Eye"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00592-022-01850-x","article-title":"A systematic review of the prevalence, risk factors and screening tools for autonomic and diabetic peripheral neuropathy in children, adolescents and young adults with type 1 diabetes","volume":"59","author":"Franceschi","year":"2022","journal-title":"Acta Diabetol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2337\/dc17-0179","article-title":"Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for diabetes in youth study","volume":"40","author":"Jaiswal","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1399-5448.2002.30107.x","article-title":"Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus","volume":"3","author":"Salem","year":"2002","journal-title":"Pediatr. Diabetes"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s43054-022-00126-x","article-title":"Urinary N-Acetyl-\u03b2-D glucosaminidase (uNAG) levels as an early marker for diabetic nephropathy in children with type 1 diabetes","volume":"70","author":"Ghobrial","year":"2022","journal-title":"Egypt. Pediatr. Assoc. Gaz."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00467-010-1443-z","article-title":"Normal-range albuminuria does not exclude nephropathy in diabetic children","volume":"25","author":"Zachwieja","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4274\/jcrpe.2002","article-title":"Neutrophil gelatinase-associated lipocalin as an early sign of diabetic kidney injury in children","volume":"7","author":"Bundak","year":"2015","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/pedi.13019","article-title":"Urinary cyclophilin A and serum cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes","volume":"21","author":"Salem","year":"2020","journal-title":"Pediatr. Diabetes"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00467-015-3253-9","article-title":"Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes","volume":"31","author":"Suh","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"ref_39","first-page":"126","article-title":"Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria","volume":"9","author":"Hafez","year":"2015","journal-title":"Iran. J. Kidney Dis."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ugarte, F., Santapau, D., Gallardo, V., Garfias, C., Yizmeyi\u00e1n, A., Villanueva, S., Sep\u00falveda, C., Rocco, J., Pasten, C., and Urquidi, C. (2022). Urinary extracellular vesicles as a source of NGAL for diabetic kidney disease evaluation in children and adolescents with type 1 diabetes mellitus. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.654269"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Trutin, I., Bajic, Z., Turudic, D., Cvitkovic-Roic, A., and Milosevic, D. (2022). Cystatin, C. Renal resistance index, and kidney injury molecule-1 are potential early predictors of diabetic kidney disease in children with type 1 diabetes. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.962048"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Stankute, I., Radzeviciene, L., Monstaviciene, A., Dobrovolskiene, R., Danyte, E., and Verkauskiene, R. (2022). Serum cystatin C as a biomarker for early diabetic kidney disease and dyslipidemia in young type 1 diabetes patients. Medicina, 58.","DOI":"10.3390\/medicina58020218"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mamilly, L., Mastrandrea, L.D., Vasquez, C.M., Klamer, B., Kallash, M., and Aldughiem, A. (2021). Evidence of early diabetic nephropathy in pediatric type 1 diabetes. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.669954"},{"key":"ref_44","first-page":"232","article-title":"NGAL and cystatin C: Two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: One year follow up","volume":"14","author":"Skevaki","year":"2015","journal-title":"Hormones"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00467-018-4062-8","article-title":"Transforming growth factor-\u03b21 in children with diabetic nephropathy","volume":"34","author":"Sawires","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/jpc.15884","article-title":"Toll-like receptor inflammatory cascade and the development of diabetic kidney disease in children and adolescents with type 1 diabetes","volume":"58","author":"Ururahy","year":"2022","journal-title":"J. Paediatr. Child. Health"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s43054-024-00290-2","article-title":"Systemic immune-inflammatory index and systemic inflammation response index in predicting renal impairment in children with type 1 diabetes mellitus","volume":"72","author":"Elmeazawy","year":"2024","journal-title":"Egypt. Pediatr. Assoc. Gaz."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"108945","DOI":"10.1016\/j.diabres.2021.108945","article-title":"The next generation: Urinary epidermal growth factor is associated with an early decline in kidney function in children and adolescents with type 1 diabetes mellitus","volume":"178","author":"Ledeganck","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1007\/s00467-023-06019-4","article-title":"Plasma leucine-rich \u03b1-2-glycoprotein 1\u2013A novel marker of diabetic kidney disease in children and adolescents with type 1 diabetes mellitus?","volume":"38","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1007\/s00431-024-05637-w","article-title":"Serum angiopoietin-2: A promising biomarker for early diabetic kidney disease in children and adolescents with type 1 diabetes","volume":"183","author":"Salem","year":"2024","journal-title":"Eur. J. Pediatr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jdiacomp.2017.10.014","article-title":"Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes","volume":"32","author":"Adly","year":"2018","journal-title":"J. Diabetes Complicat."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.2147\/DMSO.S247062","article-title":"MicroRNAs and risk factors for diabetic nephropathy in Egyptian children and adolescents with type 1 diabetes","volume":"13","author":"Abdelghaffar","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Gong, Z., Banchs, P.A.P., Liu, Y., Fu, H., Arena, V.C., Forno, E., Libman, I., Ho, J., and Muzumdar, R. (2022). Serum \u03b1-KL, a potential early marker of diabetes complications in youth with T1D, is regulated by miRNA 192. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.937093"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4274\/jcrpe.galenos.2021.2020.0303","article-title":"Midkine: Utility as a predictor of early diabetic nephropathy in children with type 1 diabetes mellitus","volume":"13","author":"Metwalley","year":"2021","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"92196","DOI":"10.1155\/2007\/92196","article-title":"Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children","volume":"2007","author":"Zorena","year":"2007","journal-title":"Mediat. Inflamm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"614908","DOI":"10.1155\/2013\/614908","article-title":"Serum concentrations of transforming growth factor-Beta 1 in predicting the occurrence of diabetic retinopathy in juvenile patients with type 1 diabetes mellitus","volume":"2013","author":"Zorena","year":"2013","journal-title":"J. Diabetes Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5152\/eajm.2011.04","article-title":"Low serum adiponectin levels in children and adolescents with diabetic retinopathy","volume":"43","author":"Tasci","year":"2011","journal-title":"Eurasian J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/pedi.12681","article-title":"A longitudinal study of serum insulin-like growth factor-I levels over 6 years in a large cohort of children and adolescents with type 1 diabetes mellitus: A marker reflecting diabetic retinopathy","volume":"19","author":"Salemyr","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.intimp.2018.03.026","article-title":"Role of neopterin as a biochemical marker for peripheral neuropathy in pediatric patients with type 1 diabetes: Relation to nerve conduction studies","volume":"59","author":"Elbarbary","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e074992","DOI":"10.1136\/bmjopen-2023-074992","article-title":"Cross-sectional study investigating the association between inflammatory biomarkers and neuropathy in adolescents with type 1 diabetes","volume":"13","author":"Rasmussen","year":"2023","journal-title":"BMJ Open"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00592-022-01919-7","article-title":"Early marker of ocular neurodegeneration in children and adolescents with type 1 diabetes: The contributing role of polymorphisms in mir146a and mir128a genes","volume":"59","author":"Piona","year":"2022","journal-title":"Acta Diabetol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/gtmb.2018.0018","article-title":"Association of polymorphisms in CYBA, SOD1, and CAT genes with type 1 diabetes and diabetic peripheral neuropathy in children and adolescents","volume":"22","author":"Snahnicanova","year":"2018","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"849457","DOI":"10.1155\/2013\/849457","article-title":"Relationship between serum transforming growth factor \u03b2 1 concentrations and the duration of type 1 diabetes mellitus in children and adolescents","volume":"2013","author":"Zorena","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Peczy\u0144ska, J., Klonowska, B., \u017belazowska-Rutkowska, B., Polkowska, A., Noiszewska, K., Bossowski, A., and G\u0142owi\u0144ska-Olszewska, B. (2022). The relationship between selected inflammation and oxidative stress biomarkers and carotid intima-media thickness (IMT) value in youth with type 1 diabetes co-existing with early microvascular complications. J. Clin. Med., 11.","DOI":"10.3390\/jcm11164732"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/1358863X15591089","article-title":"Kallistatin as a marker of microvascular complications in children and adolescents with type 1 diabetes mellitus: Relation to carotid intima media thickness","volume":"20","author":"Andrawes","year":"2015","journal-title":"Vasc. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5152\/TurkArchPediatr.2024.23147","article-title":"Evaluation of serum advanced glycation end product levels and microvascular complications in children and adolescents with type 1 diabetes mellitus","volume":"59","author":"Acar","year":"2024","journal-title":"Turk. Arch. Pediatr."}],"container-title":["Pediatric Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7503\/16\/3\/64\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:49:20Z","timestamp":1760111360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7503\/16\/3\/64"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["pediatric16030064"],"URL":"https:\/\/doi.org\/10.3390\/pediatric16030064","relation":{},"ISSN":["2036-7503"],"issn-type":[{"value":"2036-7503","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]}}}